Business Wire

FEELM

19.5.2022 10:43:11 CEST | Business Wire | Press release

Share
FEELM Commits to Net-zero Carbon Emissions By 2050

FEELM, the flagship atomization tech brand belonging to SMOORE, today released its “Race to Zero” plan and roadmap to carbon neutrality. The plan brings forward FEELM’s ambitions to achieve net-zero carbon emissions by 2050 in its direct production activities and indirect purchased energy (scope 1&2). Meanwhile, FEELM makes a commitment that renewable energies will account for 30% of its total energy consumption by 2030.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220519005482/en/

As one of China’s first atomization tech brands to make a carbon neutrality commitment, FEELM pledges to reach net zero in full supply chain and full product lifespan by developing sustainable products, improving energy efficiency with automated production, supporting the supply chain in decarbonization, and increasing renewable energies and eco-friendly materials.

FEELM, being the world ‘s largest closed vape system solution provider, plays a significant role in the global vaping supply chain. On the one hand, it provides millions of global consumers with premium product experience by virtue of partnership with vaping brands around the world; on the other hand, FEELM has been leading a sustainable revolution in the supply chain.

Leading on Sustainability by introducing FUTURE series solutions

FEELM has been leading on sustainability and green product innovations, which is the industry’s driving force towards carbon neutrality. Committed to providing global customers with zero carbon technologies, FEELM has introduced FUTURE series solutions, which feature recyclability, disassemblability, biodegradability and minimalist design.

Since 2019, FEELM has already pioneered a number of green vaping solutions. For example, it won iF Design Award 2020 for disposable paper e-cigarette, which is made up of spiral composite paper tube, improving the degradability rate to approximately 76% of the total volume, compared with the plastic used in traditional vaping products.

Moreover, FEELM is ready to unveil another eco-friendly non-nicotine disposable e-cigarette at Vaper Expo UK 2022 in late May . This product was awarded Red Dot Awards for Product Design 2022. Its external structure is composed of recyclable and reusable aluminum foil. It looks like a paper foil pouch and itself serves as a packaging bag, hence the reduction of packaging materials.

Supporting the Global Supply Chain in Decarbonization

In addition to developing sustainable products, FEELM has also partnered with suppliers to develop and encourage utilizing biodegradable materials while optimizing the water, electricity and gas consumption management. FEELM is also working with global customers to promote the recycling and reusing, so as to explore a feasible path towards carbon neutrality for the product lifespan and the supply chain.

As a manufacturer with environmental awareness, FEELM has supported vaping brands around the world in reducing carbon footprint and empowered our customers to achieve carbon neutrality in 2050, by eliminating unnecessary plastic packaging. For example, FEELM removed single-use plastics from packaging of one of its major customers. Having removed silicone caps from e-liquid pods, it replaced all plastic tray packaging with a pulp alternate. By 2020, FEELM had already helped this customer save over 100 tons of disposable plastics, which are equivalent to 4 million plastic bottles.

To date, China has accounted for close to 90% of global production of vaping products. As the world ‘s largest closed vape system solution provider, FEELM is devoted to facilitating carbon neutrality of the whole supply chain. It has been exploring innovative, customized carbon reduction solutions along with partners, covering a full circle from raw material supply, product design, production, consumption to recycling and reusing.

FEELM has established a series of automated production lines to optimize energy efficiency. According to its in-house greenhouse gas control and water management procedures, FEELM’s greenhouse gas emissions and water consumption have decreased by 16% and 9.4% year-on-year in 2021 respectively. For example, one of FEELM’s automatic factory has saved 2.298 million kilowatts of electricity, which is equivalent to a reduction of 601 tons of carbon emissions in 2021.

Complying with International Standards, and Making Carbon Management More Transparent

Aiming for the goal that 30% of total energy consumption will come from renewable source by 2030, FEELM is also benchmarked against the standards of international organizations. In 2022, FEELM has introduced Carbon Disclosure Project (CDP) standards to its operation and production. Moving forward, FEELM plans to set up science-based emission reduction targets by submitting to Science Based Targets initiative (SBTi).

The Science Based Targets initiative (SBTi) is a collaboration established in 2015 between CDP, the United Nations Global Compact, World Resources Institute (WRI) and the World Wide Fund for Nature (WWF). By May 11, 2022, there are 2,466 companies from more than 70 countries and regions have joined the initiative, including 152 Chinese companies and one fifth of Forbes 500 companies.

“As a pioneer in going global in Chinese vaping industry, FEELM has been leveraging its full supply chain advantages and fundamental R&D in reducing carbon footprints. As China has pledged to be carbon neutral by 2060, FEELM is ready to fulfill its carbon neutral commitment to Chinese vaping industry, so as to explore a lower-carbon, greener and more sustainable development path with cutting-edge technologies,” said Frank Han, Senior Vice President of SMOORE and President of FEELM.

Moving forward, FEELM will continue to reduce the carbon footprints of vaping products by promoting the R&D and application of innovative green technologies and eco-friendly materials. In collaboration with suppliers and clients, FEELM is also committed to exploring and developing the recycling and reusing mechanism of vape pod cartridges, thereby playing a more significant role in the decarbonization of the industry.

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

SLB Launches ExaCT Electrical Downhole CT Control System24.8.2026 13:02:00 CEST | Press release

New platform brings real-time electrical control to coiled tubing intervention, enabling greater precision, visibility and efficiency across intervention operations SLB (NYSE: SLB) today launched the ExaCT™ electrical downhole coiled tubing (CT) control system, an advanced intervention platform that introduces real-time electrical control to coiled tubing operations. By replacing pressure-dependent hydraulic actuation with electrical communication, power delivery and telemetry, the ExaCT system gives operators greater visibility, precision and control, helping improve intervention execution and reservoir access. The ExaCT system combines electrical power, telemetry and downhole measurements to enable communication with, actuation of and verification of downhole tools throughout an intervention. Continuous communication across the toolstring enables on-demand tool actuation across a wide range of intervention applications, including extended-reach and multilateral wells. The increased p

Wolters Kluwer Transforms Trusted Legal Content Into Structured, AI-Ready Intelligence That Powers the Next Wave of Legal AI24.8.2026 13:01:00 CEST | Press release

By transforming authoritative legal content into structured legal intelligence, Wolters Kluwer gives AI the context and relationships needed to deliver deeper research and higher-quality results Wolters KluwerLegal & Regulatory today announced the next evolution of Libra by Wolters Kluwer, its all-in-one Legal AI Workspace. By transforming authoritative legal sources, expert commentaries, and practical guidance into structured legal intelligence, Wolters Kluwer is making the relationships across the full breadth of its expert legal sources more explicit. This will enable deeper contextual research, more comprehensible answers, and workflow-ready results across legal work. Following the integration of Wolters Kluwer content into the Libra AI workspace in the first half of 2026, laws, rulings, expert commentaries, and practical guidance will now be linked to one another and to the matter at hand, creating a connected knowledge graph of expert-curated and authoredlegal knowledge that AI c

Daiichi Sankyo Appoints Markus Kosch to Lead Europe Business as Part of New Commercialization Organization24.8.2026 10:00:00 CEST | Press release

Daiichi Sankyo (TSE: 4568) today announced the appointment of Markus Kosch, MD, as Head of Europe Business, effective April 1, 2027. In this role, he will lead the company's European business within the new globally integrated Commercialization Unit and serve as General Manager of Daiichi Sankyo Europe GmbH, with legal responsibility for the company in Europe. The appointment reflects the next phase of growth of Daiichi Sankyo under its Five-Year Business Plan and the establishment of a new Commercialization Unit. Within this new structure, Markus Kosch will bring together the Oncology and Specialty businesses in Europe under one integrated leadership model to help bring innovative medicines to more patients across the region. For the past five years, Markus Kosch has led the Daiichi Sankyo Oncology Business Division in Europe and Canada, overseeing a period of significant growth and preparing the organization for an increasingly expanding oncology portfolio. Prior to joining Daiichi S

European Commission Approves DAYBU® (trofinetide) as the First and Only Treatment for Neurobehavioral Symptoms of Rett Syndrome in the European Union24.8.2026 09:01:00 CEST | Press release

Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that the European Commission (EC) has granted marketing authorization for DAYBU (trofinetide) for the treatment of neurobehavioral symptoms of Rett syndrome in adults and pediatric patients aged five years and older, making it the first and only treatment approved for Rett syndrome in the European Union (EU). “The approval of DAYBU marks a significant milestone for the Rett syndrome community in the EU and advances our mission to bring this innovative treatment to patients and families who have long faced a profound unmet medical need,” said Catherine Owen Adams, Acadia’s Chief Executive Officer. “For people living with Rett syndrome, a devastating rare neurodevelopmental disorder, there have been no approved treatment options in the EU. We are proud to make DAYBU available and look forward to supporting patients, caregivers, and healthcare providers gain access to treatment." The DAYBU marketing authorization in the EU is prim

ORZEYFUL (oveporexton) Approved in Japan as the First and Only Medicine to Treat the Underlying Cause of Narcolepsy Type 124.8.2026 08:36:00 CEST | Press release

Discovered by Takeda in Japan, ORZEYFUL has the Potential to Redefine Care Beyond Individual Symptom Management for Adults Living with Narcolepsy Type 1 (NT1) Landmark Phase 3 Studies Demonstrated Significant and Meaningful Improvements Across the Full Range of NT1 Symptoms Evaluated in Clinical Trials Compared to Placebo Milestone Marks Third Major Regulatory Approval Secured for ORZEYFUL Around the World Takeda (TOKYO:4502/NYSE:TAK) announced that the Japanese Ministry of Health, Labour and Welfare (MHLW) approved the use of ORZEYFUL (oveporexton) for the treatment of narcolepsy type 1 (NT1, narcolepsy with cataplexy) in adults. ORZEYFUL is a first-in-class oral orexin receptor 2 (OX2R) agonist and the only medicine indicated in Japan to treat the disease holistically rather than individual symptoms. The discovery of this new class of medicine originated in Takeda's laboratories in Japan. Takeda is proceeding with launch preparations and expects to make ORZEYFUL available as quickly

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye